AKBA
Akebia Therapeutics, Inc.
0.919$
-1.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +1,444.9% | +220.2% | +28.8% | +110.0% | +21.3% | +173.6% | -22.6% | -16.5% | -17.8% | -32.7% | -32.1% | -8.7% | +70.6% | |
| – | +1,389.9% | +230.5% | +27.6% | +110.1% | +20.9% | +30.7% | -33.9% | +20.0% | -27.0% | -31.7% | -36.2% | -3.7% | +62.4% | |
| – | +1,192.8% | +54.5% | +51.9% | +276.3% | -62.6% | +49.2% | +41.2% | +55.1% | -34.6% | -39.6% | -52.6% | +20.8% | +256.4% | |
| – | +1,883.9% | +234.6% | +27.1% | +88.0% | +22.1% | +1.2% | -54.0% | +81.9% | -44.3% | -39.6% | -52.6% | +20.8% | +256.4% | |
| – | +58.0% | -64.5% | – | – | +1.2% | -51.3% | +133.2% | -26.5% | +80.5% | -21.9% | -2.5% | -12.5% | +36.8% | |
| – | – | – | – | – | – | +11,424,499,900.0% | +1.8% | -47.6% | -40.0% | -41.1% | -27.2% | +3.5% | -3.9% | |
| – | – | +599.8% | +157.2% | +383.7% | +38.5% | +121.8% | +29.4% | -16.9% | -21.7% | -22.8% | – | – | – | |
| – | – | – | – | – | – | – | +0.0% | +0.0% | +7.2% | +0.0% | +0.0% | +0.0% | +0.0% | |
| – | – | – | – | – | – | – | -11.3% | -50.5% | -25.0% | -33.3% | -50.0% | – | – | |
| – | -20.6% | +76.9% | +72.6% | +1,843.5% | +5.5% | +47.2% | +4.4% | +5.3% | +14.8% | -23.0% | -22.4% | -0.9% | +27.5% | |
| – | -20.7% | +76.5% | +72.4% | +862.8% | +26.3% | +84.1% | -21.7% | -10.1% | +39.5% | -50.4% | -22.9% | -19.0% | +101.4% | |
| – | – | – | – | +12.5% | +10,866.7% | +1,419.8% | -66.7% | +6.0% | +1,836.2% | -64.1% | -34.6% | -59.6% | +312.7% | |
| – | +70.8% | +183.1% | +14.4% | -11.8% | +243.2% | +511.5% | -8.4% | +5.3% | -18.7% | -46.3% | -18.8% | +3.7% | +39.6% | |
| – | – | -50.0% | +50.0% | -16.7% | -100.0% | – | – | +27.6% | -98.2% | +1,772.4% | -49.6% | +125.2% | +24.7% | |
| – | – | +238.4% | +25.9% | -48.0% | +75.2% | +432.9% | -37.9% | -37.3% | -70.1% | -92.9% | -684.8% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +47.0% | +3.5% | +71.8% | +42.5% | +15.3% | +168.7% | +1.3% | +16.9% | +19.9% | +10.1% | +2.6% | +12.5% | +21.9% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.